Patent classifications
A01N37/04
Method for impairing a Cassie-Baxter state
The present invention about using chemicals to interfere with the ability of certain arthropods to shield themselves from their external environment. It teaches to apply chemicals to a specialized portions of the arthropod's body that maintain a gaseous envelope that encoats, protects and extends from the arthropod's skin and, if present, breathing hole. This chemical application causes a failure of this protective envelope, making the arthropod vulnerable its external environment such as to pesticides and can also lead to problems with its ability to breathe.
Method for impairing a Cassie-Baxter state
The present invention about using chemicals to interfere with the ability of certain arthropods to shield themselves from their external environment. It teaches to apply chemicals to a specialized portions of the arthropod's body that maintain a gaseous envelope that encoats, protects and extends from the arthropod's skin and, if present, breathing hole. This chemical application causes a failure of this protective envelope, making the arthropod vulnerable its external environment such as to pesticides and can also lead to problems with its ability to breathe.
COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF
Compositions are provided that contain biologically active components of amniotic fluid including growth factors and other proteins, carbohydrates, lipids, and metabolites. The compositions containing biologically active components of amniotic fluid can be useful for a range of therapeutic treatments including joint and soft tissue repair, regulation of skin condition, and for use in organ preservation, such as for use in organ transplant procedures. Advantages of the compositions include that they can be reproducibly produced, without the inherent variability of amniotic fluid from individual donors, and that they are free of fetal waste.
COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF
Compositions are provided that contain biologically active components of amniotic fluid including growth factors and other proteins, carbohydrates, lipids, and metabolites. The compositions containing biologically active components of amniotic fluid can be useful for a range of therapeutic treatments including joint and soft tissue repair, regulation of skin condition, and for use in organ preservation, such as for use in organ transplant procedures. Advantages of the compositions include that they can be reproducibly produced, without the inherent variability of amniotic fluid from individual donors, and that they are free of fetal waste.
ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME
The present disclosure provides a solid composition that includes a polycarboxylic acid chelator component mixed with a water-soluble plasticizer component, and a water-soluble or water-dispersible polymer dissolved and/or dispersed in the plasticizer component. The water-soluble plasticizer component has a boiling point >105° C. and has a formula weight of less than 5000 atomic mass units. The composition comprises <10 wt % of a solvent that has a boiling point ≤100 degrees C. When mixed with deionized water at a 1:9 mass ratio, the composition forms an aqueous mixture having a pH of about 2.5-5.5. Articles that include a substrate with a first major surface having a layer comprising the composition adhered to the first major surface are also provided. Methods of treating a biofilm or a wound site with the articles are also provided.
ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME
The present disclosure provides a solid composition that includes a polycarboxylic acid chelator component mixed with a water-soluble plasticizer component, and a water-soluble or water-dispersible polymer dissolved and/or dispersed in the plasticizer component. The water-soluble plasticizer component has a boiling point >105° C. and has a formula weight of less than 5000 atomic mass units. The composition comprises <10 wt % of a solvent that has a boiling point ≤100 degrees C. When mixed with deionized water at a 1:9 mass ratio, the composition forms an aqueous mixture having a pH of about 2.5-5.5. Articles that include a substrate with a first major surface having a layer comprising the composition adhered to the first major surface are also provided. Methods of treating a biofilm or a wound site with the articles are also provided.
BROAD-SPECTRUM HERBICIDE
A systemic, broad-spectrum herbicide comprises a water-soluble extract of one or more plant parts of rhubarb and yew. The herbicide can also contain other plant material, including plant parts of Bryonia and Laburnum. The herbicide, which is based on natural products can translocate to the roots of a plant, when the herbicide is applied to an aerial part of the plant. The herbicide can eradicate grasses, mosses and weeds, including bindweed, nettles and dockweed.
BROAD-SPECTRUM HERBICIDE
A systemic, broad-spectrum herbicide comprises a water-soluble extract of one or more plant parts of rhubarb and yew. The herbicide can also contain other plant material, including plant parts of Bryonia and Laburnum. The herbicide, which is based on natural products can translocate to the roots of a plant, when the herbicide is applied to an aerial part of the plant. The herbicide can eradicate grasses, mosses and weeds, including bindweed, nettles and dockweed.
BROAD-SPECTRUM HERBICIDE
A systemic, broad-spectrum herbicide comprises a water-soluble extract of one or more plant parts of rhubarb and yew. The herbicide can also contain other plant material, including plant parts of Bryonia and Laburnum. The herbicide, which is based on natural products can translocate to the roots of a plant, when the herbicide is applied to an aerial part of the plant. The herbicide can eradicate grasses, mosses and weeds, including bindweed, nettles and dockweed.
SYNERGISTIC DISINFECTANT COMPOSITIONS HAVING ENHANCED ANTIMICROBIAL EFFICACY AND STABILITY, AND METHODS OF USING THE SAME
A synergistic disinfectant composition comprises a C1-8 organic acid, an amino acid based surfactant, an anionic surfactant, and a stabilizing agent. The C1-8 organic acid may include two or more types of the C1-8 organic acids with at least one of the C1-8 organic acids is alpha hydroxyl acid. The disinfectant composition has an antimicrobial activity of log reduction of at least 2 under Biocidal Product Registration (BPR) standard EN13727, EN1276, EN13624 or EN1499, and/or the EPA standard that applies the “Quantitative Methods for Evaluating the Activity of Microbicides used on Hard, Non-Porous Surface” issued by the Organisation for Economic Co-operation and Development (OECD). In addition, the disinfectant composition may be stable during storage and retain their antimicrobial activity after at least one month at 40° C. When desired, the synergistic disinfectant composition may further comprise an oxidizing agent.